// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Impact of elixhauser comorbidity score on the outcomes of transcatheter aortic valve replacement

V Nagaraja - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lipoprotein(a) is associated with increased calcification and disease progression in aortic stenosis patients

K H Zheng - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

MALNUTRITION AND MORTALITY IN OLDER ADULTS UNDERGOING AORTIC VALVE REPLACEMENT

Michael Goldfarb - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

VALIDATION OF OBJECTIVE SOFTWARE-BASED LESION DEMARCATION SYSTEM DURING PULMONARY VEIN ANTRUM ISOLATION

Pouria Alipour - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

FACTORS ASSOCIATED WITH IMPAIRED QUALITY OF LIFE AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY

Andrew C.T. Ha - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

MYOCARDIAL INFARCTION PRECLUDES COMPENSATORY MITRAL VALVE ENLARGEMENT IN THE DILATED LEFT VENTRICLE

Claudia Cote-Laroche - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

TRADITIONAL CARDIOVASCULAR RISK FACTORS AND THE RISK OF AORTIC VALVE DISEASE: A SYSTEMATIC REVIEW

Michael K. Wang - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

WHAT FACTORS INFLUENCE THE CHOICE OF APIXABAN, RIVAROXABAN, OR DABIGATRAN FOR STROKE PREVENTION AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE? INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY

Andrew C.T. Ha - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

rivaroxaban

[18F] FLURPIRIDAZ PET MYOCARDIAL FLOW RESERVE QUANTIFICATION USING PHARMACOLOGIC AND TREADMILL EXERCISE STRESS TESTING

Kai Yi Wu - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

flurpiridaz F 18

ROLE OF RISK FACTOR KNOWLEDGE IN THE RECOGNITION OF HEART-RELATED SYMPTOMS DIFFER ACCORDING TO GENDER

Niveditha Pattathil - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

RHEUMATIC HEART DISEASE: NEED FOR ANTIBIOTIC THERAPY AND DEVELOPMENT OF PUBLIC HEALTH EDUCATION PROGRAMS IN DEVELOPING COUNTRIES LIKE GUYANA

Ravi Ramlal - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

APABETALONE (RVX-208) MODULATES EPIGENETIC PROCESSES IN MONOCYTES AND ENDOTHELIAL CELLS AFFECTED BY DIABETES MELLITUS AND DIET THAT ENHANCE RISK OF CARDIOVASCULAR DISEASE (CVD)

Christopher Halliday - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

RVX-208

BIOIMPEDANCE PHASE ANGLE AS A BIOMARKER FOR FRAILTY AND PREDICTOR OF MORTALITY IN CARDIAC SURGERY

Louis Antoine Mullie - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PERSISTENT AORTIC STIFFNESS AND LEFT VENTRICULAR HYPERTROPHY IN CHILDREN OF PREGESTATIONAL DIABETIC MOTHERS AT 3-8 YEARS OF AGE

Victor Do - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

THE ASSOCIATION BETWEEN APPROPRIATE USE CRITERIA AND TRANSTHORACIC ECHOCARDIOGRAPHY FINDINGS

Tamryn Law - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

INDEPENDENT PREDICTORS OF LIPID-LOWERING THERAPY INTENSIFICATION AMONG PATIENTS HOSPITALIZED FOR AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE AMI-OPTIMA STUDY

Thao Huynh - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Atorvastatin

HEART FAILURE HOSPITALIZATION AND MORTALITY IN ADULTS WITH CONGENITAL HEART DISEASE

Fei Wang - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

REPEATABILITY OF SPECT MYOCARDIAL BLOOD FLOW WITH TETROFOSMIN

Terrence D. Ruddy - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

technetium tc 99m tetrofosmin Injection

AORTIC ROOT ENLARGEMENT IN REDO AORTIC VALVE REPLACEMENT WITH PREDICTED PATIENT-PROSTHESIS MISMATCH

Vincent Chauvette - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

IMPACT OF METABOLIC SYNDROME AND/OR DIABETES ON LEFT VENTRICULAR MASS IN PATIENTS WITH SEVERE AORTIC STENOSIS BEFORE AND AFTER AORTIC VALVE REPLACEMENT

Ezequiel Guzzetti - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved